Quest for the HOLY GRAILCompanies work in hunt for better fries

摘要

The quest for an improved french fry with lower acrylamide levels marches on. The second year of the National Fry Process Trials (NFPT) and the Specialty Crop Research Initiative (SCRI) Acrylamide Program will conclude with culinary testing of selected clones at the J.R. Simplot Company's Caldwell facility this past December.This fall representatives from five major french fry processors (McCain's, Lamb Weston, Cavendish, Heinz and Simplot) as well as researchers, breeders and other industry representatives met at the USDA Agricultural Research Service office in Eat GrandForks, Minn., to evaluate 88 different clones grown in four of five variety trials supported by the NFPT and the SCRI programs.Of the 81 clones from the first year's trial, 54 were resubmitted for the second year with an additional 34 clones submitted for the first year of testing. Clones came from trial centers Idaho, North Dakota, Washington and Wisconsin.